Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients

Pharmacological Research

Volumn 43, Issue 6, 2001, Pages 547-551

  Baraldo, M ^a   Pea, F ^a   Poz, D ^a   Furlanut, M ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Cyclosporine; Heart transplant; Pharmacokinetics; Therapeutic drug monitoring

Indexed keywords

CYCLOSPORIN A;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG MONITORING; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEART TRANSPLANTATION; HUMAN; MALE; MICROEMULSION; PRIORITY JOURNAL; STEADY STATE;

EID: 0034937588     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2001.0823     Document Type: Article

References (28)

1. Cyclosporine
2. Pharmacokinetic considerations in the therapeutic application of Cylosporine in renal transplantation
3. Blood concentrations and clinical effect of Cyclosporin in psoriasis
4. Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis
5. Optimization of Cyclosporine therapy with the new therapeutic drug monitoring strategies: Report from the international Neoral TDM advisory consensus meeting (Vancouver, November 1997)
6. Consensus document: Hawk's cay meeting on therapeutic drug monitoring of cyclosporine
7. Optimisation of immunosuppressive therapy using pharmacokinetic principles
8. A population pharmacokinetic model of cyclosporine in the early postoperative phase in patients with liver transplants, and its predictive performance with bayesian fitting
9. NONMEM population pharmacokinetic modeling of orally administrered cyclosporine from routine drug monitoring data after heart transplantation
10. No effect of clodronate on cyclosporine A blood levels in heart-transplant patients simultaneously treated with diltiazem and azathioprine
11. Cyclosporin clinical pharmacokinetics
12. Cyclosporine pharmacokinetics in heart transplant patients
13. Use of Cyclosporine by constant rate infusion immediately after heart transplantation
14. Effect of assay methodology on pharmacokinetic differences between cyclosporine Neoral and Sandimmune formulations
15. Effect of Hepatic dysfunction on oral cyclosporin pharmacokinetics in marrow transplant patients
16. Cyclosporine
17. Pharmacokinetics of Cyclosporine in human renal transplantation
18. Comparable bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year
19. Cyclosporine kinetics in healthy volunteers
20. Oral and intravenous disposition of cyclosporine in psoriatic patients
21. Cyclosporine kinetics in renal transplant patients as assessed by high-performance liquid chromatography and radioimmunoassay using monoclonal and polyclonal antibodies
22. Blood Cyclosporine pharmacokinetics in patients undergoing marrow transplantation
23. Critical issues in cyclosporine monitoring: Report of the task force on cyclosporine monitoring
24. Pharmacokinetics of a new microemulsion formulation of cyclosporin A [Neoral] in young patients after renal transplantation
25. Computer in Pharmacokinetics. Choosing software for clinical decision making
26. Clinical pharmacokinetics of cyclosporin